{
  "image_filename": "table_p5_det_4_004.png",
  "image_path": "Zimmerman_et_al.__2023_/extracted/figures/table_p5_det_4_004.png",
  "image_type": "Table",
  "page_number": 5,
  "block_id": "det_4_004",
  "claim_id": "claim_000",
  "claim": "Flublok ensures identical antigenic match with WHO- and FDA-selected flu strains.",
  "supports_claim": false,
  "explanation": "A table listing percentage estimates (with 95% confidence intervals) for relative vaccine effectiveness of Flublok (RIV4) versus standard-dose quadrivalent inactivated influenza vaccines (SD-IIV4), stratified by overall population, sex, age groups, high-risk condition status, and influenza seasons, with adjustments using multivariable models, propensity scores, and inverse probability weighting. does not support the claim because the table provides relative effectiveness data and does not present any information on antigenic matching to WHO- or FDA-selected influenza strains.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A table listing percentage estimates (with 95% confidence intervals) for relative vaccine effectiveness of Flublok (RIV4) versus standard-dose quadrivalent inactivated influenza vaccines (SD-IIV4), stratified by overall population, sex, age groups, high-risk condition status, and influenza seasons, with adjustments using multivariable models, propensity scores, and inverse probability weighting.",
    "evidence_found": null,
    "reasoning": "does not support the claim because the table provides relative effectiveness data and does not present any information on antigenic matching to WHO- or FDA-selected influenza strains.",
    "confidence_notes": null
  }
}